These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 21567423)

  • 21. Interferon-alpha and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis.
    Cacoub P; Lidove O; Maisonobe T; Duhaut P; Thibault V; Ghillani P; Myers RP; Leger JM; Servan J; Piette JC
    Arthritis Rheum; 2002 Dec; 46(12):3317-26. PubMed ID: 12483738
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sustained virologic response to treatment in 100% of patients recently infected, nosocomially, with HCV genotype 2.
    Sikuler E; Tur-Kaspa R; Shemer-Avni Y; Delgado J; Zilberman D; Fich A; Baruch Y; Hyam E
    J Clin Gastroenterol; 2008 Jul; 42(6):730-3. PubMed ID: 18574394
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Acute hepatitis C: response to treatment with interferon-alpha plus ribavirin].
    Vega Palomares R; Planas Vilà R; Durández Lazaro R; Fábregas Puigtió S
    Gastroenterol Hepatol; 2002 Oct; 25(8):483-6. PubMed ID: 12361528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pilot study on the safety and efficacy of intravenous natural beta-interferon therapy in patients with chronic hepatitis C unresponsive to alpha-interferon.
    Mazzoran L; Grassi G; Giacca M; Gerini U; Baracetti S; Fanni-Canelles M; Zorat F; Pozzato G
    Ital J Gastroenterol Hepatol; 1997 Aug; 29(4):338-42. PubMed ID: 9476188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High titers of antibodies inhibiting the binding of envelope to human cells correlate with natural resolution of chronic hepatitis C.
    Ishii K; Rosa D; Watanabe Y; Katayama T; Harada H; Wyatt C; Kiyosawa K; Aizaki H; Matsuura Y; Houghton M; Abrignani S; Miyamura T
    Hepatology; 1998 Oct; 28(4):1117-20. PubMed ID: 9755251
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The German Hep-Net acute hepatitis C cohort: impact of viral and host factors on the initial presentation of acute hepatitis C virus infection.
    Deterding K; Wiegand J; Grüner N; Hahn A; Jäckel E; Jung MC; Buggisch P; Galle P; Berg T; Hinrichsen H; Potthoff A; Zeuzem S; Cornberg M; Manns M; Wedemeyer H
    Z Gastroenterol; 2009 Jun; 47(6):531-40. PubMed ID: 19533544
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HIV and HCV co-infection: situation at six French university hospitals in the year 2000.
    Buffet-Janvresse C; Peigue-Lafeuille H; Benichou J; Vabret A; Branger M; Trimoulet P; Goria O; Laurichesse H; Abbed A; Verdon R; Bouvet E; Lafon ME; Dussaix E; Cormerais L; Dupon M; Henquell C; Josse A; Lagoutte P; Lariven S; LeGac S; Riachi G; Verdon R; Vittecoq D;
    J Med Virol; 2003 Jan; 69(1):7-17. PubMed ID: 12436472
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lack of seroconversion in a health care worker after polymerase chain reaction-documented acute hepatitis C resulting from a needlestick injury.
    Morand P; Dutertre N; Minazzi H; Burnichon J; Pernollet M; Baud M; Zarski JP; Seigneurin JM
    Clin Infect Dis; 2001 Sep; 33(5):727-9. PubMed ID: 11477531
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence, risk factors, and genotype distribution of hepatitis C virus infection in the general population: a community-based survey in southern Italy.
    Guadagnino V; Stroffolini T; Rapicetta M; Costantino A; Kondili LA; Menniti-Ippolito F; Caroleo B; Costa C; Griffo G; Loiacono L; Pisani V; Focà A; Piazza M
    Hepatology; 1997 Oct; 26(4):1006-11. PubMed ID: 9328327
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of human leucocyte alpha-interferon treatment for chronic hepatitis C virus infection.
    Weiland O; Chen M; Lindh G; Mattsson L; Schvarcz R; Sönnerborg A; Wahl M; Wejstål R; Widell A; Norkrans G
    Scand J Infect Dis; 1995; 27(4):319-24. PubMed ID: 8658063
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low accuracy of the national reporting system of acute hepatitis C infection in Taiwan, 1995-2004.
    Kee KM; Hung CM; Wang JH; Hung CH; Chen PF; Lin KS; Lu SN
    J Gastroenterol Hepatol; 2010 Jul; 25(7):1289-94. PubMed ID: 20594258
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence and clinical outcome of hepatitis C infection in children who underwent cardiac surgery before the implementation of blood-donor screening.
    Vogt M; Lang T; Frösner G; Klingler C; Sendl AF; Zeller A; Wiebecke B; Langer B; Meisner H; Hess J
    N Engl J Med; 1999 Sep; 341(12):866-70. PubMed ID: 10498458
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A comparison of the prevalence of autoantibodies in individuals with chronic hepatitis C and those with autoimmune hepatitis: the role of interferon in the development of autoimmune diseases.
    Bayraktar Y; Bayraktar M; Gurakar A; Hassanein TI; Van Thiel DH
    Hepatogastroenterology; 1997; 44(14):417-25. PubMed ID: 9164512
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chronic hepatitis C virus infection in renal transplant: treatment and outcome.
    Sharma RK; Bansal SB; Gupta A; Gulati S; Kumar A; Prasad N
    Clin Transplant; 2006; 20(6):677-83. PubMed ID: 17100715
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk Factors for Hepatitis C Virus (HCV) Infection in Areas with a High Prevalence of HCV in the Republic of Korea in 2013.
    Sohn HS; Kim JR; Ryu SY; Lee YJ; Lee MJ; Min HJ; Lee J; Choi HY; Song YJ; Ki M
    Gut Liver; 2016 Jan; 10(1):126-32. PubMed ID: 26260752
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Full or partial seroreversion in patients infected by hepatitis C virus.
    Lefrère JJ; Guiramand S; Lefrère F; Mariotti M; Aumont P; Lerable J; Petit JC; Girot R; Morand-Joubert L
    J Infect Dis; 1997 Feb; 175(2):316-22. PubMed ID: 9203652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sustained viral response of a case of acute hepatitis C virus infection via needle-stick injury.
    Kogure T; Ueno Y; Kanno N; Fukushima K; Yamagiwa Y; Nagasaki F; Kakazu E; Matsuda Y; Kido O; Nakagome Y; Ninomiya M; Shimosegawa T
    World J Gastroenterol; 2006 Aug; 12(29):4757-60. PubMed ID: 16937453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Distinct features in natural history and outcomes of acute hepatitis C.
    Bunchorntavakul C; Jones LM; Kikuchi M; Valiga ME; Kaplan DE; Nunes FA; Aytaman A; Reddy KR; Chang KM
    J Clin Gastroenterol; 2015 Apr; 49(4):e31-40. PubMed ID: 24457946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Epidemiologic and therapeutic status study of patients with hepatitis C].
    Xu M; Shi HY; Cai WP
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2011 Apr; 25(2):135-6. PubMed ID: 21863640
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?].
    Kubitschke A; Bader C; Tillmann HL; Manns MP; Kuhn S; Wedemeyer H
    Internist (Berl); 2007 Oct; 48(10):1165-72. PubMed ID: 17684714
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.